Jon Stonehouse

SendInBlue Mimecast WP Engine Adobe Marketing Cloud Salesforce Gravity Forms WordPress.org reCAPTCHA New Relic Mobile Friendly Google Tag Manager Remote

drug discovery clinical development rare diseases regulatory affairs product commercialization biotechnology life sciences biotechnology: biological products (no diagnostic substances) health care biotechnology research pharmaceuticals drug development clinical trials oral small-molecule therapeutics protein therapeutics hereditary angioedema c1 esterase inhibitor plasma kallikrein inhibitors complement-mediated diseases novel therapies patient advocacy compassionate use programs expanded access programs medical information research partnerships fda approvals pediatric patients targeted therapies medicinal chemistry structure-guided drug design innovative medicines biopharmaceuticals patient-centric approach healthcare professionals scientific research collaborative research advanced technologies patient outcomes community engagement regulatory compliance global markets phase clinical trials real-world effectiveness patient-reported outcomes breakthrough therapies translational research unmet medical needs pharmaceutical collaborations clinical research integrity evolution of drug design healthcare accessibility charitable contributions medical education grants research & development patient privacy assurance advocacy organizations transformative treatments oral therapeutics innovative therapies antiviral treatments structure-guided approach fda-approved products healthcare providers global presence niche market collaboration therapeutic development healthcare innovation pharmaceutical industry commercial-stage biotech revenue growth market expansion specialized treatments healthcare stakeholders disease management therapeutic pipeline health wellness & fitness medical hospital & health care